• Title/Summary/Keyword: Dose Evaluation

Search Result 1,869, Processing Time 0.024 seconds

Dose Assessment in Accordance with the Measured Position of Size Specific Dose Estimates (Size Specific Dose Estimates(SSDE)측정 위치에 따른 피폭선량 평가)

  • Kim, Jung-Su;Hong, Sung-Wan;Kim, Jung-Min
    • Journal of radiological science and technology
    • /
    • v.38 no.4
    • /
    • pp.383-387
    • /
    • 2015
  • This study investigated the size specific dose estimates of difference localizer on pediatric CT image. Seventy one cases of pediatric abdomen-pelvic CT (M:F=36:35) were included in this study. Anterior-posterior and lateral diameters were measured in axial CT images. Conversion factors from American Association of Physicists in Medicine (AAPM) report 204 were obtained for effective diameter to determine size specific dose estimate (SSDE) from the CT dose index volume (CTDIvol) recorded from the dose reports. For the localizer of mid-slice SSDE was 107.63% higher than CTDIvol and that of xiphoid-process slices SSDE was higher than 92.91%. The maximum error of iliac crest slices, xiphoid process slices and femur head slices between mid-slices were 7.48%, 17.81% and 14.04%. In conclusion, despite the SSDE of difference localizer has large number of errors, SSDE should be regarded as the primary evaluation tool of the patient radiation in pediatric CT for evaluation.

A Study for Dose-Reduction of Antipsychotics in Chronic Schizophrenics (만성 정신분열병 환자에서 항정신병약물 감량에 관한 연구)

  • Hwang, Tae-Yeon;Lee, Min Soo;Kim, Hyeong-Seob
    • Korean Journal of Biological Psychiatry
    • /
    • v.5 no.2
    • /
    • pp.263-277
    • /
    • 1998
  • Conventional high-dose antipsychotics tend to result in more side effects, negative symptoms and dysphoria, and at the same time lower the cognitive function which is already impaired in most schizophrenics. Florid psychotic symptoms, negative symptoms and cognitive impairment greatly impede psychosocial performance and eventual reintegration into society. The reduction of symptom and the improvement of cognitive funtions and social skills are therefore central to the psychiatric rehabilitation process. The purpose of this study was to evaluate the dose-reduction effects of antipsychotics on chronic schizophrenics prescribed conventional high-dose antipsychotics more than 1,500mg equivalent of chlorpromazine. Fifty-one chronic schizophrenics who maintained high-dose antipsychotics for more than three months were randomly assigned to two groups : 20 patients comprised the dose-maintaining group and 31 patients made the dose-reduction group. Over a sixteen weekperiod Positive and Negative Syndrome Scale(PANSS), Extrapyramidal Symptom(EPS), Nurses' Observation Scale for Inpatient Evaluation(NOSIE-30), Continuous Performance Test(CPT), Quality of Life(QOL), and haloperidol/reduced haloperidol blood levels were determined at the base line and after 2, 4, 6, 8, 12, 16 weeks to evaluate the dose reduction effects of high-dose antipsychotics. The results were as follows : 1) Dose-reduction is highly effective in reducing positive and negative symptoms, and general psychopathology. Effects were most prominent at 8, 12, 16 weeks. Among the dose reduction group, positive symptoms in positive symptom group and negative symptoms in negative symptom group were more reduced. 2 Extrapyramidal symptoms showed no significant difference between two groups. But the EPS was reduced time after time within two groups. 3) Hit rates of Continuous Performance Test, which indicate attentional capacity, increased significantly after dose reduction. 4) Haloperidol and reduced haloperidol blood levels decreased until the 4th week, after which they were constant. 5) Total scores of Nurses' Observation Scale for Inpatient Evaluation were unchanged between the two groups. But among the indices, social interest and personal neatness were improved in the dose-reduction group and retardation was aggrevated in the dose-maintaining group. 6) Total quality of life scores were unchanged between two groups. But in the dose maintaining group, satisfaction scores of attention, autonomy, and interpersonal relationship decreased progressively. These findings suggest that the dose reduction of antipsychotics for chronic schizophrenics on programs of high-dose antipsychotics were effective. Dose reduction should therefore be implemanted to spread the rehabilitation and improve quality of life for chronic schizophrenics.

  • PDF

Definition and Difference between Dose Equivalent and Equivalent Dose in Radiation Dose Measurement and Evaluation (방사선량의 측정, 평가에서 선량당량(dose equivalent)과 등가선량(equivalent dose)의 정의 및 차이)

  • Chang, Si-Young
    • Journal of Radiation Protection and Research
    • /
    • v.18 no.1
    • /
    • pp.1-7
    • /
    • 1993
  • In its recent recommendation No. 60(1990), ICRP has newly introduced several terminology which had not existed in its prior recommendation No. 26(1977). Of these, a newly defined quantity 'Equivalent Dose' replacing the 'Dose Equivalent' of the ICRU concept has been recommended to be adopted in the radiation protection programme. However, since the committee still uses the 'Dose Equivalent' and 'Equivalent Dose' in its several publications, it is likely to provoke unnecessary confusions and misuses in applying these two quantities. In this paper were described the definition and difference between these two quantities to help in understanding of these two quantitites among the person involved in the radiation protection activities.

  • PDF

Assessment of External Radiation Dose for Workers in Domestic Water Treatment Facility According to the Working Type (국내 수처리시설 종사자 작업유형에 따른 외부피폭방사선량 평가)

  • Seong Hun Jeon;Seong Yeon Lee;Hyeok Jae Kim;Min Seong Kim;Kwang Pyo Kim
    • Journal of Radiation Industry
    • /
    • v.17 no.2
    • /
    • pp.151-160
    • /
    • 2023
  • The International Atomic Energy Agency (IAEA) proposes 11 industries that handle Naturally Occurring Radioactive Material (NORM) that are considered to need management. A water treatment facility is one of the above industries that takes in groundwater and produces drinking water through a water treatment process. Groundwater can accumulate natural radionuclides such as uranium and thorium in raw water by contacting rocks or soil containing natural radionuclides. Therefore, there is a possibility that workers in water treatment facilities will be exposed due to the accumulation of natural radionuclides in the water treatment process. The goal of this study is to evaluate the external radiation dose according to the working type of workers in water treatment facilities. In order to achieve the above goal, the study was conducted by dividing it into 1) analysis of the exposure environment, 2) measurement of the external radiation dose rate 3) evaluation of the external radiation dose. In the stage of analyzing the exposure environment, major processes that are expected to occur significantly were derived. In the measurement stage of the external radiation dose rate, a map of the external radiation dose rate was prepared by measuring the spatial radiation dose rate in major processes. Through this, detailed measurement points were selected considering the movement of workers. In the external radiation dose evaluation stage, the external radiation dose was evaluated based on the previously derived external radiation dose rate and working time. As a result of measuring the external radiation dose rate at the detailed points of water treatment facilities A to C, it was 1.90×10-1 to 3.75×100 μSv h-1, and the external radiation dose was analyzed as 3.27×10-3 to 9.85×10-2 mSv y-1. The maximum external radiation dose appeared during the disinfection and cleaning of activated carbon at facility B, and it is judged that natural radionuclides were concentrated in activated carbon. It was found that the external radiation dose of workers in the water treatment facility was less than 1mSv y-1, which is about 10% of the dose limit for the public. As a result of this study, it was found that the radiological effect of external radiation dose of domestic water treatment facility workers was insignificant. The results are expected to contribute as background data to present optimized safety management measures for domestic NORM industries in the future.

Storge Stability of Barleys Irradiated by Gamma-Ray (감마선 조사에 보리의 저장 안전성)

  • 김미라;손인숙
    • Journal of the Korean Society of Food Science and Nutrition
    • /
    • v.28 no.5
    • /
    • pp.1076-1081
    • /
    • 1999
  • Physicochemical, microbiological, and sensory properties of barleys irradiated by gamma ray at 1.2kGy, 10.1kGy, or 30.5kGy were investigated every 40 days during the storage at 25℃ and 50% relative humidity. Moisture content of the irradiated barleys decreased but crude lipid content increased during the storage. TBA values increased in proportion to the irradiation dose and to the storage period. In Hunter's color, L, a, and b values of 30.5kGy dose irradiated barleys were higher than those of the non irradiated barleys right after irradiation and this trend continued during the storage. Numbers of mesophilic and psychrophilic bacteria in the non irradiated barleys and 1.2kGy dose irradiated barleys were higher than those in the barleys irradiated at 10.1kGy and 30.5kGy during the storage. Numbers of yeasts and molds in the irradiated and non irradiated barleys were low and they did not greatly increase during the storage. In sensory evaluation, acidic odor of the barleys was strong at the 10.1kGy and 30.5 kGy dose irradiation but barley odor and humid odor were not significantly different among the groups depending upon the radiation dose and storage period.

  • PDF

Evaluation of Anticancer Activity of Curcumin Analogues Bearing a Heterocyclic Nucleus

  • Ahsan, Mohamed Jawed
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.4
    • /
    • pp.1739-1744
    • /
    • 2016
  • We report herein an in vitro anticancer evaluation of a series of seven curcumin analogues (3a-g). The National Cancer Institute (NCI US) Protocol was followed and all the compounds were evaluated for their anticancer activity on nine different panels (leukemia, non small cell lung cancer, colon cancer, CNS cancer, melanoma, ovarian cancer, renal cancer, prostate cancer and breast cancer) represented by 60 NCI human cancer cell lines. All the compounds showed significant anticancer activity in one dose assay (drug concentration $10{\mu}M$) and hence were evaluated further in five dose assays (0.01, 0.1, 1, 10 and $100{\mu}M$) and three dose related parameters $GI_{50}$, TGI and $LC_{50}$ were calculated for each (3a-g) in micro molar drug concentrations (${\mu}M$). The compound 3d (NSC 757927) showed maximum mean percent growth inhibition (PGI) of 112.2%, while compound 3g (NSC 763374) showed less mean PGI of 40.1% in the one dose assay. The maximum anticancer activity was observed with the SR (leukemia) cell line with a $GI_{50}$ of $0.03{\mu}M$. The calculated average sensitivity of all cell lines of a particular subpanel toward the test agent showed that all the curcumin analogues showed maximum activity on leukemia cell lines with $GI_{50}$ values between 0.23 and $2.67{\mu}M$.

Preliminary Evaluation of Radiological Impact for Domestic On-road Transportation of Decommissioning Waste of Kori Unit 1

  • Dho, Ho-Seog;Seo, Myung-Hwan;Kim, Rin-Ah;Kim, Tae-Man;Cho, Chun-Hyung
    • Journal of Nuclear Fuel Cycle and Waste Technology(JNFCWT)
    • /
    • v.18 no.4
    • /
    • pp.537-548
    • /
    • 2020
  • Currently, radioactive waste for disposal has been restricted to low and intermediate level radioactive waste generated during operation of nuclear power plants, and these radioactive wastes were managed and disposed of the 200 L and 320 L of steel drums. However, it is expected that it will be difficult to manage a large amount of decommissioning waste of the Kori unit 1 with the existing drums and transportation containers. Accordingly, the KORAD is currently developing various and large-sized containers for packaging, transportation, and disposal of decommissioning waste. In this study, the radiation exposure doses of workers and the public were evaluated using RADTRAN computational analysis code in case of the domestic on-road transportation of new package and transportation containers under development. The results were compared with the domestic annual dose limit. In addition, the sensitivity of the expected exposure dose according to the change in the leakage rate of radionuclides in the waste packaging was evaluated. As a result of the evaluation, it was confirmed that the exposure dose under normal and accident condition was less than the domestic annual exposure dose limit. However, in the case of a number of loading and unloading operations, working systems should be prepared to reduce the exposure of workers.

Comparative Evaluation of Two-dimensional Radiography and Three Dimensional Computed Tomography Based Dose-volume Parameters for High-dose-rate Intracavitary Brachytherapy of Cervical Cancer: A Prospective Study

  • Madan, Renu;Pathy, Sushmita;Subramani, Vellaiyan;Sharma, Seema;Mohanti, Bidhu Kalyan;Chander, Subhash;Thulkar, Sanjay;Kumar, Lalit;Dadhwal, Vatsla
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.11
    • /
    • pp.4717-4721
    • /
    • 2014
  • Background: Dosimetric comparison of two dimensional (2D) radiography and three-dimensional computed tomography (3D-CT) based dose distributions with high-dose-rate (HDR) intracavitry radiotherapy (ICRT) for carcinoma cervix, in terms of target coverage and doses to bladder and rectum. Materials and Methods: Sixty four sessions of HDR ICRT were performed in 22 patients. External beam radiotherapy to pelvis at a dose of 50 Gray in 27 fractions followed by HDR ICRT, 21 Grays to point A in 3 sessions, one week apart was planned. All patients underwent 2D-orthogonal and 3D-CT simulation for each session. Treatment plans were generated using 2D-orthogonal images and dose prescription was made at point A. 3D plans were generated using 3D-CT images after delineating target volume and organs at risk. Comparative evaluation of 2D and 3D treatment planning was made for each session in terms of target coverage (dose received by 90%, 95% and 100% of the target volume: D90, D95 and D100 respectively) and doses to bladder and rectum: ICRU-38 bladder and rectum point dose in 2D planning and dose to 0.1cc, 1cc, 2cc, 5cc, and 10cc of bladder and rectum in 3D planning. Results: Mean doses received by 100% and 90% of the target volume were $4.24{\pm}0.63$ and $4.9{\pm}0.56$ Gy respectively. Doses received by 0.1cc, 1cc and 2cc volume of bladder were $2.88{\pm}0.72$, $2.5{\pm}0.65$ and $2.2{\pm}0.57$ times more than the ICRU bladder reference point. Similarly, doses received by 0.1cc, 1cc and 2cc of rectum were $1.80{\pm}0.5$, $1.48{\pm}0.41$ and $1.35{\pm}0.37$ times higher than ICRU rectal reference point. Conclusions: Dosimetric comparative evaluation of 2D and 3D CT based treatment planning for the same brachytherapy session demonstrates underestimation of OAR doses and overestimation of target coverage in 2D treatment planning.

Evaluation of Dynamic Delivery Quality Assurance Process for Internal Target Volume Based RapidArc

  • Song, Ju-Young
    • Progress in Medical Physics
    • /
    • v.28 no.4
    • /
    • pp.181-189
    • /
    • 2017
  • The conventional delivery quality assurance (DQA) process for RapidArc (Varian Medical Systems, Palo Alto, USA), has the limitation that it measures and analyzes the dose in a phantom material and cannot analyze the dosimetric changes under the motional organ condition. In this study, a DQA method was designed to overcome the limitations of the conventional DQA process for internal target volume (ITV) based RapidArc. The dynamic DQA measurement device was designed with a moving phantom that can simulate variable target motions. The dose distribution in the real volume of the target and organ-at-risk (OAR)s were reconstructed using 3DVH with the ArcCHECK (SunNuclear, Melbourne, USA) measurement data under the dynamic condition. A total of 10 ITV-based RapidArc plans for liver-cancer patients were analyzed with the designed dynamic DQA process. The average pass rate of gamma evaluation was $81.55{\pm}9.48%$ when the DQA dose was measured in the respiratory moving condition of the patient. Appropriate method was applied to correct the effect of moving phantom structures in the dose calculation, and DVH data of the real volume of target and OARs were created with the recalculated dose by the 3DVH program. We confirmed the valid dose coverage of a real target volume in the ITV-based RapidArc. The variable difference of the DVH of the OARs showed that dose variation can occur differently according to the location, shape, size and motion range of the target. The DQA process devised in this study can effectively evaluate the DVH of the real volume of the target and OARs in a respiratory moving condition in addition to the simple verification of the accuracy of the treatment machine. This can be helpful to predict the prognosis of treatment by the accurate dose analysis in the real target and OARs.

Antigenicity of HRccine (HFRS-vaccine) in Guinea Pigs and Mice (기니픽과 마우스에서 HRccine(HFRS 바이러스 백신)의 항원성 시험)

  • 백영옥;손정진;안세헌;김태성;이상옥;이영수;조정식
    • Toxicological Research
    • /
    • v.11 no.1
    • /
    • pp.157-159
    • /
    • 1995
  • A study on antigenicity of HRccine (formalin inactivated HFRS virus vaccine) was investigated in guinea pigs and mice. As a part of the safety evaluation of the HRccine, antigenicity tests were carried out according to the Estabilish Regulations of National Institute of Safety Research. In active systemic anaphylaxis (ASA) test no sign was detected when sensitized with up to 120 clinical dose and challenged with up to 1200 clinical dose in guinea pigs. In passive systemic anaphylaxis test guinea pigs showed no sign. In passive cutaneous anaphylaxis (PCA) test, HRccine specific IgE antibody was not detected when sensitized and challenged with up to 1200 clinical dose. Conclusively, there was no adverse antigenic potential at the clinical dose of 120 clinical dose alone and 120 clinical dose with Al(OH)3.

  • PDF